🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 48344T209
- Market Cap
- Micro Cap · $12 Million
- Previous Symbol
- KBIO (changed 1/13/2016)
Business: KaloBios Pharmaceuticals, Inc. is a monoclonal antibody company focused on developing innovative therapies to benefit patients with diseases of unmet medical need, with a focus on oncology.
Notes: July 13, 2015 -- KaloBios Pharmaceuticals, Inc. (KBIO) will effect a one for eight (1-8) reverse stock split of its outstanding common stock. The reverse split will be effective at the opening of business on Tuesday, July 14, 2015. In conjunction with the reverse split, the CUSIP number will change to 48344T209.
Company Contact
- CEO
- Herb C. Cross (Interim)
- CFO
- Herb C. Cross
- Headquarters
- 442 Littlefield Avenue, South San Francisco, CA 94080
- Phone
- 650-243-3100
- Investor Relations
- Herb C. Cross · 650-243-3114 · ir@kalobios.com